Ropes & Gray represented Prevail Therapeutics on the deal Investors in the round included OrbiMed, Pontifax, RA Capital, EcoR1 Capital, Omega Funds, BVF Partners L.P., Boxer…
Prevail Therapeutics’ $75 million Series A financing
Ropes & Gray represented Prevail Therapeutics on the deal Investors in the round included OrbiMed, Pontifax, RA Capital, EcoR1 Capital, Omega Funds, BVF Partners L.P., Boxer…